Skip to main content
. 2019 May 30;12(2):91–96. doi: 10.14802/jmd.18049

Table 2.

Mean age and frequency of MVI, B12, or MVI + B12 use by age range

Age at diagnosis NoB12Supp MVI B12 B12 + MVI p-value
n = 617 (54%) n = 466 (41%) n = 26 (2%) n = 38 (3%)
< 50 yrs
 Number of subjects 99 (66) 48 (32) 2 (1) 2 (1) 0.02*
 Age 44.3 ± 4.6 44.73 ± 4.6 47.5 ± 2.1 48.0 ± 1.4 0.52
50–59 yrs
 Number of subjects 219 (58) 146 (39) 6 (1) 7 (2) 0.07*
 Age 54.9 ± 2.8 55.12 ± 2.9 55.5 ± 3.2 56.3 ± 3.6 0.51
60–69 yrs
 Number of subjects 209 (48) 200 (46) 9 (2) 18 (4) 0.01*
 Age 64.1 ± 2.8 64.11 ± 2.8 64.22 ± 3.4 63.4 ± 2.9 0.77
≥ 70 yrs
 Number of subjects 90 (49) 72 (40) 9 (5) 11 (6) 0.01*
 Age 73.4 ± 3.1 73.6 ± 3.2 72.8 ± 1.8 1.4 ± 1.9 0.16

Data are presented as a number (percentage) or mean ± SD.

*

group comparison of number using Fisher’s exact test for each age subgroup,

group comparison of age using ANOVA for each age subgroup,

p = 0.038 pairwise comparison by Hochberg test. MVI: multivitamin.